![Cynthia Diltz](https://neuronext.org/sites/neuronext.org/files/styles/medium/public/diltz_1.jpg?itok=Q9Fb3ixB)
Ms. Diltz is a Protocol Monitor at the DCC and has over 30 years of experience managing clinical trials and monitoring for regulatory compliance. Ms. Diltz is ACRP-certified as a Clinical Research Coordinator (CCRC). Ms. Diltz was the primary monitor for the NN104 RHAPSODY study, and will be the primary monitor for the NN109 MAGINE study.
Email: